Company details
Our Partners
-
Interactive cluster mapInteractive cluster mapFind more information on the players of the Bavarian biopharma ecosystem.
Bio<sup>M</sup> Community Network
BioM Community Network
Your contact
Dr. Andreas Berghammer
Community Services & Business Strategy Lead
4SC AG
4SC is a clinical-stage biopharmaceutical company developing small-molecule drugs that target key indications in cancer with high unmet medical need.
4SC's pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: resminostat.
4SC had 46 employees as of 31 December 2021 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C4).
4SC's pipeline is protected by a comprehensive portfolio of patents and currently comprises one drug candidate in clinical development: resminostat.
4SC had 46 employees as of 31 December 2021 and is listed on the Prime Standard of the Frankfurt Stock Exchange (FSE Prime Standard: VSC; ISIN: DE000A3E5C4).
Categories:
Biotech Therapeutics & Diagnostics
Deutschland-82152 Planegg-Martinsried
Telephone: +49 (0) 89 700763-0
Fax: +49 (0) 89 700763-29